CYTK financials
Cytokinetics (CYTK) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
CYTK income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $88.04M | $77.91M | -$612.26M | -$784.96M | -6.54 |
| 2024 | $18.47M | -$320.93M | -$536.25M | -$589.53M | -5.26 |
| 2023 | $7.53M | -$322.59M | -$496.20M | -$526.24M | -5.45 |
| 2022 | $94.59M | -$146.22M | -$324.20M | -$388.95M | -4.33 |
| 2021 | $70.43M | -$89.51M | -$186.31M | -$215.31M | -2.80 |
| 2020 | $55.83M | -$41.12M | -$93.94M | -$127.29M | -1.97 |
- CYTK revenue was $88.04M in fiscal 2025, net income -$784.96M.
Updated 2026-11-02 23:14 UTC